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Introduction
It is essential to achieve the objectives of improving 
vaccination policy and maintaining vaccination cover-
age if the “suspension of mandatory vaccination” in the 
Veneto Region is to be maintained. To this end, activi-
ties are being carried out to raise public awareness, to 
implement ongoing training for healthcare workers and 
to perform continual (6-monthly) monitoring of vacci-
nation coverage rates. 
As part of its plans to improve the vaccination system, 
the Veneto Region has introduced a New Vaccination 
Calendar for the developmental age (DGR 4403/05 and 
DGR 411/08). The aim is to consolidate the high levels of 
coverage of the formerly mandatory vaccinations and to 
introduce, in a regime of active call, the anti-pneumococ-
cal conjugate, anti-meningococcal C (age-cohorts: 13th 
month, 6th year and 15th year) and anti-varicella vaccines.
Among the actions related to the these activities, other 
projects have been planned and implemented. One such 
project is the “Surveillance of meningitis and pathologies 
related to the newly introduced vaccinations”, which has 
been incorporated into the 2010-2012 Regional Preven-
tion Plan.
The aims of the present study were to describe the ex-
perience of the Veneto Region in the field of invasive 
diseases, to assess the coverage rates achieved and to 
present the preliminary data collected by the meningitis 
surveillance system. 
Materials and methods
The data on anti-pneumococcal, anti-meningococcal 
C and anti-haemophilus influenzae type B vaccina-
tions were taken from a dedicated form, “Annex C” to 
DGR 2043/2006, which was correlated with the new 
vaccination calendar for the developmental age (DGR 
4403/2005 and subsequent modifications, DGR 411/08; 
Tab. I) and completed by the Local Health Authorities in 
the Veneto Region. 
The denominator was taken as the number of subjects 
eligible for vaccination in each individual age-class, 
with reference to the 1st, 2nd and 3rd doses of the anti-
pneumococcal and anti-haemophilus influenzae type B 
vaccines and to the single dose of the anti-meningococ-
cal C vaccine.
In January 2007, a system of active surveillance of inva-
sive bacterial diseases was implemented in the Veneto 
Region with the aim of continuously monitoring the epi-
demiological trends of these diseases. The data used are 
collected by the microbiology laboratories of the hospi-
tals and local health authorities.
Results
The data from the 6-monthly reports reveal that in the 
Veneto Region the level of vaccination coverage with re-
gard to Haemophilus influenzae type B is close to the 95% 
threshold indicated in the National Vaccine Plan (Fig. 1).
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Summary
The goal of this study was to describe and comment the experience 
of the Veneto Region in the bacterial invasive disease. Vaccina-
tion coverage was 93% against pneumococcus and 95% against 
haemophilus influenzae type B. Regard to meningococcus C the 
coverage rate was 90.1% In children, 81% at
6 years of age and 78.2% at 15 years . The preliminary data of 
an active surveillance of invasive bacterial diseases show that 
the Streptoccoccus pneumoniae was the main agent involved 
and that its consequences were particularly serious in elderly 
subjects. With regard to Neisseria meningitidis, we observed a 
substantial reduction in the number of cases due to serogroup 
C and a concomitant rise in the percentage of cases due to 
serogroup B. The suspension of mandatory vaccination should 
be maintained , the monitoring of vaccination coverage and 
the active surveillance proved to be a very good assessment 
tools.
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With regard to the anti-pneumococcal vaccine, the mean 
regional coverage rate for the first dose was 93.5% for 
the cohort born in the first semester of 2011 (measured 
on 30.09.2011); this was slightly lower than the figure 
recorded in the cohort born in the second semester of 
2010 (93.8%). When the coverage rate is broken down 
by Local Health Authority area, it emerges that, among 
subjects born in the first semester of 2011, coverage 
of more than 90% was achieved in 19 of the 21 Local 
Health Authority areas in the Region (Fig. 2). 
The mean vaccination coverage against meningococcal C 
among the cohort born in the first semester of 2010 proved 
to be 90.1%, a slightly higher value than that recorded 
among those born in the second semester of 2009. For 
anti-meningococcal C vaccination, coverage rates were 
Fig. 1. vaccination coverage rates for haemophilus influenzae 
type B in subjects aged 24 months and birth cohorts (veneto 
region).
Fig. 2. vaccination coverage rates for pneumococcus conjugate, by local health authority; cohorts born in 1st semester 2011 (veneto 
region). 
Tab. I. vaccination calendar of the veneto region (dgr 411 of 26 February 2008).
Active call, free of charge Free of charge
Vaccine Birth 3rd 
month
5th 
month
13th 
month
14th 
month
15th 
month
6th year 12th year 15th year 65 years > 65 years
dtp  dtap dtap dtap   dtap  dtap   
tetanus          tetanus 2  
ipv  ipv ipv ipv   ipv     
hepatitis B hB3 hB hB hB        
hib  hib hib hib        
mprv     mprv  mprv4     
varicella         varicella   
pCv  pCv pCv   pCv      
men C    men C   men C  men C   
hpv        hpv    
pv 23-valent          pv 23-valent  
influenza          influenza influenza
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81% at 6 years of age and 78.2% 
at 15 years (Fig. 3).
Unlike vaccination cover-
age against pneumococcus 
conjugate, which displayed a 
slight downward trend (93.5% 
vs. 93.8%), coverage against 
meningococcus C was seen to 
be slightly higher (90.1%) than 
in the previous semester (89.7%: 
data recorded on 31/03/2011; 
subjects born in the second se-
mester, 2009).
With regard to the surveillance 
of invasive bacterial diseases in 
the period 2007-2011, the ref-
erence epidemiological centre 
received 979 forms reporting 
on 1028 samples, 66% of which 
were blood samples and 34% 
samples of cerebrospinal fluid. 
The etiological agent was identified in 83.7% of the 
samples analyzed; in 66.2% it was Streptococcus pneu-
moniae, in 8.9% Neisseria meningitidis and in 4.3% 
Haemophilus influenzae. 
Since 2007, cases due to Neisseria meningitidis sero-
group C have declined (44.4% in 2007, 20% in 2008, 
33.3% in 2009 and no case in the last two years), while 
cases due to serogroup B, against which no vaccine is 
currently available, have increased (37% in 2007, 85.7% 
in 2010 and 86.7% in 2011). The infection proved fatal 
in 10 cases: 4 due to serogroup C, 5 due to serogroup B 
(4 children under 5 years and one 56-year-old adult) and 
1 due to serogroup Y (adult).
Streptococcus pneumoniae was isolated from 543 sub-
jects: 62 (11.4%) aged less than 5 years, 186 (34.2%) 
between 30 and 64 years and 261 (48%) over 65 years 
of age.
A total of 53.6% of the samples were confirmed and 
typed in the Regional Reference Laboratory. Among 
subjects under 5 years of age, 74.3% of cases involved 
serotypes contained in the 13-valent vaccine, while 
among subjects over 65 years of age, 68.3% of cases 
involved serotypes contained in the 13-valent vaccine 
and 87.2% involved serotypes contained in the 23-
valent vaccine.
In the period examined, 42 people died as a result 
of the three microorganisms considered: 6 children 
under the age of 5 years (4 cases due to Neisseria 
meningitidis) and 25 subjects aged over 65 years (19 
cases due to Streptococcus pneumoniae). Mortality 
displays a downward trend: from 16 deaths in 2007 
to 6 in 2011.
Conclusions
With regard to the issue of whether the Veneto Region’s 
law N° 7/2007 on the suspension of mandatory vaccina-
tion for subjects of developmental age should be main-
tained, the monitoring of vaccination coverage proved to 
be a very good assessment tool. 
The data on the pathogens isolated from subjects suffer-
ing from invasive bacterial diseases revealed that Strep-
toccoccus pneumoniae was the main agent involved and 
that its consequences were particularly serious in elderly 
subjects. With regard to Neisseria meningitidis, we ob-
served a substantial reduction in the number of cases due 
to serogroup C and a concomitant rise in the percentage 
of cases due to serogroup B.
In support of the law suspending mandatory vaccination 
and of the vaccination calendar, the Regional Author-
ity has undertaken specific projects: a single software 
for the management of vaccinations, pre-vaccination 
counseling and the surveillance of adverse events, train-
ing for healthcare workers, the surveillance of vaccine-
related pathologies, the promotion of healthcare in the 
first years of life, and the surveillance and prevention of 
diseases related to travel and immigration.
To implement these projects, the Veneto Region has 
scheduled annual financing and has incorporated vacci-
nation objectives into the assessment parameters utilized 
by the General Directors of the Local Health Authorities 
(DGR 3140/2010). 
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Fig. 3. vaccination coverage rates for meningococcus C, by vaccination age and birth cohort 
(veneto region). 
